Region: Latin America & Caribbean

IAM benchmarking survey 2020

Featured in Community Insight

Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign

08 June 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments

21 May 2020

Regulatory framework – healthcare products and intellectual property in Mexico

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2020

With Mexico’s change of government, new trends and practices have been introduced, affecting, among other things, the regulatory and IP framework. This chapter contains an overview of the main ammendments made throughout 2019 and a brief discussion on what it is expected for 2020.

07 May 2020

Biologics and biosimilars in Brazil – the strategic questions

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2020

This chapter highlights the strategic questions surrounding patent prosecution, patent litigation and the regulation of biologics and biosimilars on the Brazilian market.

06 May 2020

A guide for second medical use claims in Brazil

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2020

One of the most common questions regarding patent protection in Brazil refers to whether there is a possibility of protecting second medical use of known chemical compounds. The answer is simple: yes, it is possible to protect second medical use in Brazil.

06 May 2020

How to patent second medical uses in Brazil

Innovators must overcome demanding inventive step and novelty requirements to protect repurposed drugs in Latin America’s largest market

04 May 2020

Private equity investor buys majority stake in IP pioneer Ocean Tomo

New capital will help Chicago-based business scale-up as it looks to develop new marketplace, says firm's head Jim Malackowski; possible expansion of international arm into India and Brazil also being considered

24 April 2020

Johnson & Johnson, Gilead and Roche are the world’s antiviral patent leaders

A covid-19 vaccine could be produced by anyone, but only a few major players had been actively strengthening and building their portfolios before the pandemic struck

17 April 2020

World leaders hatch further plans for accessibility of covid-19 IP rights

WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests

09 April 2020

From the IAM archive – the decision makers

A selection of some of the exclusive interviews we have run with the indviduals running the world's most important patent offices

08 April 2020

Unlock unlimited access to all IAM content